June 2024
Shaker Mousa, Ph.D., M.B.A., FACC, FACB, Albany College of Pharmacy and Health Sciences
ORI found that Respondent engaged in research misconduct by intentionally, knowingly, or recklessly falsifying and/or fabricating chick chorioallantoic membrane (CAM) assays used to determine angiogenesis activities of small molecules in (2) published papers.
May 2024
Darrion Nguyen, Baylor College of Medicine
ORI found that Respondent engaged in research misconduct by intentionally, knowingly, or recklessly falsifying and/or fabricating experimental data and results that were included in one (1) RPPR, one (1) presentation, one (1) poster, six (6) research records, and two (2) figures of a prospective manuscript.
April 2024
Gian-Stefano Brigidi, Ph.D. University of California San Diego and University of Utah
ORI found that Respondent engaged in research misconduct by knowingly or intentionally falsifying and/or fabricating data and results by manipulating primary data values to falsely increase the n-value, manipulating fluorescence micrographs and their quantification graphs to augment the role of ITFs in murine hippocampal neurons, and/or manipulating confocal images that were obtained through different experimental conditions in twenty (20) figures of one (1) published paper and four (4) PHS grant applications, one (1) panel of one (1) poster, and seven (7) slides of one (1) presentation.
November 2023
Sarah Elizabeth Martin, Auburn University
ORI found that Respondent engaged in research misconduct by intentionally or knowingly falsifying and/or fabricating experimental data and results obtained under different experimental conditions that were included one (1) grant application, one (1) published paper, one (1) submitted manuscript, and six (6) presentations.
October 2023
Lara S. Hwa, Ph.D., Baylor University and University of North Carolina at Chapel Hill
ORI found that Respondent engaged in research misconduct by knowingly or recklessly falsifying and/or fabricating data, methods, results, and conclusions in animal models of alcohol use disorders. Specifically, Respondent falsified and/or fabricated experimental timelines, group conditions, sex of animal subjects, mouse strains, and behavioral response data in two (2) published papers and two (2) PHS grant applications.